Navigation Links
Prefilled Syringes Market Expected to Reach USD 4.98 Billion Globally in 2019: Transparency Market Research
Date:11/21/2013

ALBANY, New York, November 21, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," the global prefilled syringes market was valued at USD 2.09billion in 2012 and is expected to grow at a CAGR of 13.3% from 2013 to 2019, to reach an estimated value of USD 4.98billion in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/prefilled-syringes-market.html

Prefilled syringes are advanced drug delivery devices filled with single measured dose of high-end injectable drugs. Thesesyringes are gradually becoming the most preferred delivery devices for various categories of injectable drugs, mainly due to the advantages offered to drug manufacturers, healthcare providers and patients over conventional vial and ampoule packaging systems. To drug manufacturers, they are important because they reduce overfill to 4%-5% from 20% in vials, and thus, are preferred for dispensing therapeutic classes (mainly biologics) which are expensive. With respect to healthcare providers and patients, prefilled syringes help with factors such as ease of operation, low risk of contamination and accurate dosing.

Glass has been the most preferred material over decades for syringe manufacturing, owing to its properties such as non-reactive nature, robustness, transparency and tolerability against heat. Consequently, glass based prefilled syringes accounted for the larger share(more than 90%) of the total market in 2012, both by revenue as well as volume.Sincethe past few years, the industry is witnessing a shift towards the usage of plastic in place of glass in response to some significant disadvantages associated with glass, such as high risk of breakability and increased level of leachability from silicone layer in the presence of biologics. Under the influence of continued development in the area of polymer technology, the market for plastic based syringes is expected to grow at a CAGR more than double of that of glass syringes duringthe forecast period from 2013 to 2019. Nevertheless, glass syringes will still dominate the total global market for prefilled syringes in 2019, in terms of percent share by revenue as well as volume.

Boost in the use of biologics and other potent injectable drugs, technical advances in prefilled syringe manufacturing and packaging, rising demand for self-administration and increasing elderly population suffering from various chronic diseases that require frequent parenteral dosing are some major drivers anticipated totrigger market growth during the forecast period. On the other hand, burgeoning concerns regarding needlestick safety and prevention, rising manufacturing costs and issues with drug stability are some of the challenges likely to affect the growth of the global prefilled syringes market.

Geographically, Europe constituted the largest market share for prefilled syringes in 2012, owing to the high adoption rate of these delivery devices in the region. However, the North American market is predicted to grow at a higher CAGR (15%) than Europe during the forecast period to reach a value similar to that of the European market. Major drivers expected to contribute to this market growth include increasing awareness regarding benefits of prefilled syringes and presence of a large number of biopharmaceuticals under clinical development targeted for parenteral administration. In addition, the high growth economies of emerging nations such as India, China, Brazil, Russia and Mexico are attracting manufacturers to invest in these lucrative markets. Japan is a well-established market for prefilled syringes among Asian countries.

The market for prefilled syringes is oligopolistic in nature and is dominated by a few key players, namely, Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. Other vendors operating in the market include Unilife Corporation, West Pharmaceutical Services, Inc., Baxter International, Inc. and Ypsomed Holding AG.

Related & Recently Published Reports by Transparency Market Research


The global prefilled syringes market is segmented as follows:

Prefilled Syringes Market, by Segment

  • Glass Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)
    • Plastic Prefilled Syringes Market
    • By Revenue (USD Million)
    • By Volume (Million units)

Prefilled Syringes Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/
Blog: http://udallas.academia.edu/transparencymarketresearch/


'/>"/>
SOURCE http://www.transparencymarketresearch.com/
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
7. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
8. GeneLink Marketing Efforts Poised to Show Results
9. Animal Biotechnology - Technologies, Markets and Companies
10. Gene Therapy - Technologies, Markets and Companies
11. Biomarkers - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... April 27, 2016 MedDay, a biotechnology ... announces the appointment of Catherine Moukheibir as Chairman of its ... Chairman, Jean Jacques Garaud , who contributed to the ... effective immediately. Catherine started her career in strategy ... and London .  She held C-Suite level ...
(Date:4/26/2016)... CAMBRIDGE, Mass. (PRWEB) , ... April 26, 2016 , ... ... Herr has been selected as one of three finalists for the European Inventor ... the EPO’s annual innovation prize will be announced at a ceremony in Lisbon on ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., a ... round of financing. Healthy investor interest drove significant oversubscription of the original $1.5M ... known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and President, ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):